Literature DB >> 10632112

Endothelin-1 in the brain of patients with galactosialidosis: its abnormal increase and distribution pattern.

K Itoh1, K Oyanagi, H Takahashi, T Sato, Y Hashizume, M Shimmoto, H Sakuraba.   

Abstract

Endothelin-1 is a peptidic substrate in vitro of lysosomal protective protein/cathepsin A (PPCA) with serine carboxypeptidase activity. Endothelin-1-specific immunoreactivity has been demonstrated to be markedly increased and distributed abnormally in the neurons and glial cells within autopsied brain regions, including the cerebellum, hippocampal formation, and spinal cord, of patients affected with galactosialidosis, a human PPCA deficiency. The genetic defect of the endothelin-1 degrading activity of PPCA is suggested to cause some of the neurological abnormalities of this disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632112

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

1.  Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease.

Authors:  Alessandra d'Azzo; Erik Bonten
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

2.  Protective protein/cathepsin A down-regulates osteoclastogenesis by associating with and degrading NF-kappaB p50/p65.

Authors:  Masaaki Masuhara; Takuya Sato; Naoto Hada; Yoshiyuki Hakeda
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

3.  Lysosomal Cathepsin A Plays a Significant Role in the Processing of Endogenous Bioactive Peptides.

Authors:  Zehra Kevser Timur; Secil Akyildiz Demir; Volkan Seyrantepe
Journal:  Front Mol Biosci       Date:  2016-10-25

4.  Mice with Catalytically Inactive Cathepsin A Display Neurobehavioral Alterations.

Authors:  O Y Calhan; V Seyrantepe
Journal:  Behav Neurol       Date:  2017-01-04       Impact factor: 3.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.